Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring

Diabetes

Volumn 54, Issue 7, 2005, Pages 2026-2031

  Kagohashi, Yukiko ^a   Udagawa, Jun ^a   Abiru, Norio ^b   Kobayashi, Masakazu ^b   Moriyama, Kenji ^a   Otani, Hiroki ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; EMBRYO TRANSFER; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; HEREDITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; ONSET AGE; PANCREAS ISLET BETA CELL; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROGENY;

ANIMALS; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INSULIN ANTIBODIES; MALE; MICE; MICE, INBRED DBA; MICE, INBRED ICR; MICE, INBRED NOD;

EID: 21344463312     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.7.2026     Document Type: Article

References (27)

1. Atkinson MA, MacLaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
2. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
3. Leslie DG, Elliott RB: Early environmental events as a cause of IDDM. Diabetes 43:843-850, 1994
4. Clarke WL, Shaver KA, Bright GM, Rogol AD, Nance WE: Autoimmunity in congenital rubella syndrome. J Pediatr 104:370-373, 1984
5. Rubinstein P, Walker ME, Fedun B, Witt ME, Cooper LZ, Ginsberg-Fellner F: The HLA system in congenital rubella patients with and without diabetes. Diabetes 31:1088-1091, 1982
6. Rabinowe SL, George KL, Loughlin R, Soeldner JS, Eisenbarth GS: Congenital rubella: monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 81:779-782, 1986
7. Greeley SAW, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H: Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399-402, 2002
8. Koczwara K, Ziegler AG, Bonifacio E: Maternal immunity to insulin does not affect diabetes risk in progeny of non obese diabetic mice. Clin Exp Immunol 136:56-59, 2004
9. Otani H, Tanaka O, Tatewaki R, Naora H, Yoneyama T: Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40:1245-1250, 1991
10. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 93:2260-2263, 1996
11. Hogan B, Beddington R, Costantini F, Lacy E: Recovery, culture, and transfer of embryos. In Manipulating the Mouse Embryo. 2nd ed. Cold Spring Harbor, NY, Section C, Cold Spring Harbor Laboratory Press, 1994, p. 173-181
12. Sermeus W, Delesie L: Ridit analysis on ordinal data. West J Nurs Res 18:351-359, 1996
13. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS: Early expression of anti-insulin autoantibodies of man and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 97:1701-1706, 2000
14. Shanks N, Lightman SL: The maternal-neonatal neuro-immune interface: are there long-term implications for inflammatory or stress-related disease? J Clin Invest 108:1567-1573, 2001
15. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A: B-cells are required for the initiation of insulitis in nonobese diabetic mice. Diabetes 46:941-946, 1997
16. Serreze DV, Chapman HD, Varnum DS: B lymphoctes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 184:2049-2053, 1996
17. Akashi T, Nagafuchi S, Anzai K: Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 9:1159-1164, 1997
18. Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV: The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 32:3657-3666, 2002
19. Eckenrode SE, Ruan G, Yang O, Zheng W, McIndoe RA, She JX: Gene expression profiles define a key checkpoint for type 1 dibetes in NOD mice. Diabetes 53:366-375, 2004
20. Warram JH, Krolewski AS, Gottliem MS, Kahn RC: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149-152, 1984
21. Tillil H, Kobbering J: Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36:93-99, 1987
22. Yu L, Chase HP, Falorni A, Rewers M, Lernmark A, Eisenbarth GS: Sexual dimorphism in transmission of expression of islet antoantibodies to offspring. Diabetologia 38:1353-1357, 1995
23. Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP. DPT-1 Participating Investigators: Diabetes Prevention Trial 1: prevalence of GAD and ICA 512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci 958:254-258, 2002
24. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 93:956-960, 1996
25. Tominaga Y, Nagata M, Yasuda H, Okamoto N, Arisawa K, Moriyama H, Miki M, Yokono K, Kasuga M: Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin Immunol Immunopathol 86:209-218, 1998
26. Herrera E, Lasuncion MA, Huerta L, Martin-Hidalgo A: Plasma leptin levels in rat mother and offspring during pregnancy and lactation. Biol Neonate 78:315-320, 2000
27. Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, Cava AL: Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51:1356-1361, 2002